{
    "2021-03-26": [
        [
            {
                "time": "",
                "original_text": "万泰生物去年营收翻倍扣非净利增274% 股价跌1.7%",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "营收翻倍",
                        "扣非净利",
                        "股价下跌"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "每日“药”闻|蓝帆医疗商誉减值17.6亿；多家药企公布业绩，先声药业利润下滑34%",
                "features": {
                    "keywords": [
                        "蓝帆医疗",
                        "商誉减值",
                        "先声药业",
                        "利润下滑"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：二价HPV疫苗上市7月贡献7亿收入，加大推广销售费增一倍至7亿",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "HPV疫苗",
                        "收入增长",
                        "销售费用增加"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "交卷！万泰生物：2020年度净利润约6.77亿元，同比增加224.13%",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "2020年度",
                        "净利润",
                        "同比增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}